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 Headaches are a common complaint for children presenting to the Emergency 
Department (ED) at Connecticut Children’s Medical Center. Currently, there is little 
published regarding a standard treatment plan for pediatric headaches. The purpose of this 
study is to determine which medications are most commonly utilized and which are most 
effective in managing pediatric headaches. Differences in management of acute and chronic 
headaches in the ED at Connecticut Children’s Medical Center were examined. A 
retrospective chart review was conducted of all children who presented to the ED from 
January 1 to March 31, 2013 with a chief complaint or discharge diagnosis with the term 
“headache” or “migraine”. Data collection included medications administered in the ED, 
intensity of headache (pain score scaled 1-10) before and after medication, and disposition 
(home or admitted). Acute headaches were defined as headaches lasting 1-7 days and 
chronic headaches as lasting more than 7 days. Of 165 children who presented to the ED at 
Connecticut Children’s Medical Center with headaches in 2013, 72.7% presented with 
acute headaches, while 27.3% presented with chronic headaches. The most common 
medications used to manage headaches in this ED are Ibuprofen, Toradol, IV fluid (NaCl), 
Reglan and Acetaminophen. It cannot be assumed that one medication brought the pain 
score down because multiple drugs were administered. Therefore, efficacy of individual 
drugs could not be determined. Ibuprofen was used more frequently to manage acute 
headaches, while Reglan and Benadryl were used more often for chronic headache 
management. This study can be a basis for future prospective studies that examine 
medication efficacy in managing pediatric headaches, ultimately resulting in the 




Pediatric headaches are a common health problem. In 1962, Bille (Bille, 1962) 
observed a 40% prevalence of headaches in children by age seven and 75% prevalence by 
the age of fifteen. This study, which was the first to provide a comprehensive epidemiologic 
report on pediatric headaches, showed that the prevalence of headaches in children 
increases during adolescence. A twenty-year study demonstrated that 73% of children who 
presented with headaches continued to experience headaches as an adult (Brna, Dooley, 
Gordon, & Dewan, 2005). In addition, during preteen years, headaches are more prevalent 
in males than in females, however during adolescence, headaches occur more frequently in 
females than males (Abu-Arafeh & Russell, 1994; McGrath & Hillier, 2001).  
Headaches affect children in multiple ways, including academically, mentally and 
socially. Moreover, headaches are the third leading illness resulting in missed days of 
school for children (Brna, Dooley, Gordon, & Dewan, 2005). Children who experience 
recurrent headaches are particularly impacted. Children with frequent headaches not only 
miss more school than their peers, their academic performance is often impaired as well 
(Allen, 2006). Also, pediatric headaches can lead to changes in personality and a decline in 
social function (Allen 2006).   
While migraine headaches are common in children, the most frequent type of 
headache affecting children is the tension headache, which can last between 30 minutes 
and 7 days.  It is characterized by a pressing or tightening pain that may extend to the neck 
and upper back (Cummings, Wittick, Cantor, 2009). Tension headaches, which can be 
triggered by stress, depression, anxiety or decreased quality of sleep, tend to occur on the 
weekdays in the daytime, consistent with school hours (Cummings, Wittick, Cantor, 2009).  
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Genizi and colleagues conducted a study in 2013 that examined the frequency of 
learning disabilities and attention-deficit hyperactivity disorder (ADHD) in children who 
experience migraine and tension type headaches (Genizi et al., 2013). They found a 40.7% 
prevalence of either ADHD, learning disabilities or both conditions in children with tension 
and migraine headaches (Genizi et al., 2013). Furthermore, ADHD had a more significant 
impact on the children with tension headaches in comparison to those with migraine 
headaches (Genizi et al., 2013). Genizi and colleagues also observed that children with 
migraine headaches performed better in school than children with tension headaches 
(Genizi et al., 2013).  
Although headache classification guidelines have been established by the 
International Headache Society (The Headache Classification Committee of the 
International Headache Society, 1988, 2004), there has been much dispute on how to 
approach and manage pediatric headaches. Recommendations for management of pediatric 
headaches have been based on studies of adult headaches. Currently, medications such as 
Ibuprofen, Acetaminophen, Sumatriptan, Toradol (Ketorolac), Reglan (Metoclopramide), 
Ondansetron, Naproxen, Amitriptyline, Flunarizine and Prochlorperazine are used to treat 
children (Rosenblum & Fisher, 2001; Walker&Teach, 2008; Gelfand & Goadsby, 2012). 
Additionally, some non-pharmacological methods have been used. These include change in 
diet and increased exercise (Molofsky 1998).  
Pediatric headache complaints are common in emergency departments, such as the 
Emergency Department (ED) at Connecticut Children’s Medical Center. While some 
children may visit their primary care physician for treatment of headaches, children often 
visit pediatric emergency departments instead. Adolescents tend to present to emergency 
 14 
departments with headaches more frequently than younger children, partly because 
headaches become more prevalent as children age (Gelfand & Goadsby, 2012). In the ED at 
Connecticut Children’s Medical Center, a trial and error approach is often used for 
headache management. Therefore, in this study, we determined which medications are 
most commonly used to manage pediatric headaches and examined the efficacy of the 
medications used in the ED. We also assessed differences in management of acute and 
chronic headaches because they usually have different etiologies. Causes of acute 
headaches include upper respiratory infections, trauma, endocrine disorders and 
meningitis, while post-concussive syndrome, psychological issues and brain abscesses are 
among the causes of chronic headaches (Cummings, Wittick, Cantor, 2009). Our goal is to 
use this information to eventually develop treatment guidelines for the ED at Connecticut 

























We reviewed 165 patient charts of children ages 5 to 17 that presented to the ED at 
Connecticut Children’s Medical Center, an urban pediatric hospital, from January 1 to 
March 31, 2013 with a chief complaint or discharge diagnoses with the term “headache” or 
“migraine”. We used the Picis ED Pulsecheck charting system to review the charts (Figure 
1). We collected the following data: age, acute vs. chronic headache, intensity of headache 
(pain score scaled 1-10) before and after medication administration, medications 
administered in the ED, prescriptions written in the ED for home, and disposition (home or 
admitted). Acute headaches were defined as headaches lasting 1-7 days and chronic 
headaches as lasting more than 7 days. Children who left before evaluation or against 
medical advice were excluded from this study. Statistical Package for the Social Science 
(SPSS) software was utilized to perform statistical analysis of the data. Pearson’s Chi-
Square test was used to compare the quantitative variables in the acute and chronic 
headache groups (Table 1). Table 1 shows the results of a Pearson’s Chi-Square test 
performed to examine the correlation between the frequency of a medication with respect 
to its use for treatment of acute vs. chronic headaches. Other variables were analyzed using 
the Independent Samples t-test (Table 2a, 2b). Tables 2a and 2b show the results of an 
Independent Samples t-test done to investigate the association between a medication and 











Figure 1. Example of a hypothetical patient chart in Picis ED PulseCheck. Source: YouTube. 































Initial review indicated that in 2013, there were 1,400 pediatric complaints and/or 
diagnoses of general headaches, migraine headaches, and post-concussion headaches in the 
Emergency Department (ED) at Connecticut Children’s Medical Center. In this study, we 
reviewed 165 of the charts for the children who presented with headaches that year. 
Patient age and gender were assessed because these factors are associated with pediatric 
headaches. As shown in Table 3, the median age of children in our sample is 12 years, 
which is early adolescence. Consistent with earlier studies (Abu-Arafeh & Russell, 1994; 
McGrath & Hillier, 2001), females in this group are somewhat more affected by headaches 
than are males. In addition, we observed that acute headaches account for approximately 
three fourths of headaches while the remaining one fourth are chronic headaches. We also 
observed that almost all children were sent home rather than admitted with serious 
neurological disorders that required urgent care. Furthermore, a pain score decrease was 
achieved in three fourths of the cases, indicating pediatric headache management in the ED 
was effective overall.  
Table 3. Patient Characteristics  
Total Patients 165 
Mean Age 12.25 years 
Gender Female 55.6% 
Male 44.4% 












We recorded the percentage of children who were given each medication to 
determine which medications are most commonly utilized in the ED at Connecticut 
Children’s Medical Center (Table 4). 
Table 4. Medications Administered to 165 Children Presenting with Headache in 2013 













Benadryl  12.4% 
 
 As shown in Table 4, the most common medications used to treat pediatric 
headaches in the ED at Connecticut Children’s Medical Center are Ibuprofen, 
Acetaminophen, Toradol, IV fluid (NaCl), and Reglan.  
The medications used in the ED at Connecticut Children’s Medical Center were 
correlated with pain score to determine the effectiveness of the medications. The intensity 
of the headaches was measured using a pain scale of 1-10, which was recorded before and 
after medication administration. To assess effectiveness, we examined the change in pain 
score for the children. If the children’s pain score decreased after medications were given, 
the medications were considered to be effective. If the children’s pain score did not 
decrease after treatment, the medications were deemed as not effective. While 76.3% of the 
children reported feeling less pain by the end of their emergency department visit, it was 
difficult to measure which specific medications were associated with this decrease. While 
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some children were treated using only one medication, one specific medication alone was 
insufficient to treat most children’s headaches. Therefore, the children were often given 
multiple medications during their stay in the ED, and it is likely that the combination of 
medications administered is what actually caused most children’s pain score to decrease. 
This may be indicative of a possible synergistic effect between the medications being used 
in the ED at Connecticut Children’s Medical Center. As such, we cannot assume that any one 
medication brought the pain score down. This was demonstrated when we attempted to 
perform statistical analysis, as the data produced insignificant and misleading results. For 
these reasons, we cannot make statistically significant conclusions about medication 
efficacy based on the data.  
Additionally, for each medication administered, we assessed its frequency of use for 
treatment of acute and chronic headaches to determine if there was a difference in 
headache management based on type. 
 





























We found a statistically significant difference in the administration of Ibuprofen, 
Reglan, and Benadryl to treat acute and chronic headaches in the ED at Connecticut 
Children’s Medical Center. Ibuprofen was prescribed significantly more frequently (p < 
0.05) for the treatment of patients with acute headaches than chronic headaches (Figure 4). 
In contrast, there was no statistically significant difference (p > 0.05) between the use of 
Acetaminophen in the management of acute or chronic headaches. In addition, the use of 
Triptan, Ondansetron, Narcotic, Toradol and IV fluid showed no significant differences for 
treatment of acute and chronic headaches. Furthermore, the use of Reglan (p < 0.01) and 
Benadryl (p < 0.01) both exhibited statistically significant differences in the treatment of 
acute and chronic headaches (Figure 4). Both were used more frequently to treat children 
with chronic headaches than acute headaches. None of the children in this cohort were 
given Benzodiazephine, Prochlorperazine, Topamax, or Amitriptyline for headache 























To optimize patient care at Connecticut Children’s Medical Center, it is important to 
develop headache treatment guidelines for this ED. Rather than a trial and error method of 
treatment which can be time consuming and frustrating, a standard pediatric headache 
treatment plan could provide more structure to the treatment process. Health care 
providers could use the treatment guidelines to determine which medications are most 
appropriate to manage a child’s headache. To further this goal, we determined which 
specific medications have been commonly used to manage pediatric headaches in the ED at 
Connecticut Children’s Medical Center. For instance, contrary to practices in other pediatric 
emergency departments, medications such as Amitriptyline, Sumatriptan, Flunarizine, 
Naproxen, and Prochlorperazine were not used to treat any of the children presenting to 
the ED at Connecticut Children’s Medical Center (Rosenblum & Fisher, 2001; 
Walker&Teach, 2008; Gelfand & Goadsby, 2012). 
In this study, we have determined that Ibuprofen, Acetaminophen, Toradol, IV fluid 
(NaCl), and Reglan have been utilized the most to manage pediatric headaches in the ED at 
Connecticut Children’s Medical Center. The next step in developing treatment guidelines 
involves assessing the effectiveness of these medications in a prospective study. 
Additionally, the differences in management for type of headache should be further 
researched because we found a significant difference in the administration of Ibuprofen, 
Reglan, and Benadryl with respect to treatment of acute and chronic headaches. Benadryl, 
which is not generally used as often as Ibuprofen or Reglan to treat headaches in the ED at 
Connecticut Children’s Medical Center, is particularly significant for treating chronic 
headaches.   
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 For children with acute headaches, Ibuprofen is the ideal medication to administer 
first. This has been supported by studies conducted by Hämäläinen, Hoppu and Valkeila 
(1997) and Lewis and colleagues (2002). The 1997 study showed that Ibuprofen was 
superior to a placebo and Acetaminophen in improving acute headache pain (Hämäläinen 
et al., 1997). Similarly, in the 2002 study, it was concluded that Ibuprofen is an effective, 
well-tolerated pain medication for children who experience acute headaches (Lewis et al., 
2002).  
For children with chronic headaches, medications such as Reglan and Benadryl can 
be initially used for treatment. In a 2013 study conducted by Friedman and colleagues, they 
compared the use of a combination of Metoclopramide (Reglan) and Diphenhydramine 
(Benadryl) to Ketorolac (Toradol) for treatment of adult recurrent headaches. The study 
showed that the Reglan and Benadryl combination was superior to Toradol in relieving 
recurrent headache pain (Friedman et al., 2013). While this study was conducted with 
adults, it is consistent with our findings for children. A study similar to the Friedman study 
conducted with children would contribute to the development of a standard pediatric 
headache management plan.  
Based on our study, we cannot assume that the decrease in pain score was 
associated with any one medication, as more than one medication is usually administered 
to the children at approximately the same time. It is pertinent to note that since 76.3% of 
the children who presented to ED reported a lower pain score after medication was 
administered, it is plausible that most of the medications being used were effective. 
Furthermore, the method used to measure efficacy in this study was not sufficient in 
providing conclusive results. This can be improved by separating the children into two 
 14 
groups, one being those whom received one medication and the other would consist of 
children who received more than one medication. This way, we could measure efficacy 
based on how treatment was provided.  
This is a small study with only 165 charts audited. A larger sample size might have 
produced additional significant correlations. Moreover, this study was limited in that it was 
retrospective. However, the results we found can form the basis of future prospective 
studies on headache management in the pediatric emergency department. For example, 
future research can determine which combinations of the commonly utilized medications 
are most associated with a decrease in pain score and shorter emergency department 
length of stay for children. Additionally, other potential studies could examine how 
comorbidities and headache triggers impact the intensity of pediatric headaches and 
ultimately, which medications are effective in treating children in the emergency 
department. Furthermore, children often receive over-the-counter medications prior to 
their emergency department visit. It is possible that these medications affect the efficacy of 
the medications administered in the pediatric emergency department. The implications of 
these and other future studies could advance the management of pediatric headaches and 
emphasize the significance of studies being conducted on children to understand how to 
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